DonateGlycogen Storage Disease Type II (GSD II)
Breeds
Relevance Rating: There is some evidence or research available for these breeds
Relevance Rating: The test is unknown, there is no evidence (i.e. research) available, or it has not been evaluated yet. These tests may or may not be meaningful for these breeds
GTPs
General
Disease Name
Glycogen Storage Disease Type II (GSD II)
Mutation
c.2237G>A
Details
Glycogen Storage Disease alters the enzyme glucose-6-phosphatase, a key step in the production of glucose, to be deficient. This leads to chronic low blood sugar, liver damage and premature death. Generalised symptoms of Glycogen Storage Disease in dogs includes weakness, chronic low blood sugar, collapse, lethargy, enlarged, liver anorexia. Age of onset from birth/puppyhood. Specific to Type II: pups vomit frequently, progressive muscle weakness and poor body condition, esophageal dilation and cardiac enlargement. Death before the age of two years.
Details 2
Glycogen Storage Disease alters the enzyme glucose-6-phosphatase, a key step in the production of glucose, to be deficient. This leads to chronic low blood sugar, liver damage and premature death. Generalised symptoms of Glycogen Storage Disease in dogs includes weakness, chronic low blood sugar, collapse, lethargy, enlarged, liver anorexia. Age of onset from birth/puppyhood. Specific to Type II: pups vomit frequently, progressive muscle weakness and poor body condition, esophageal dilation and cardiac enlargement. Death before the age of two years.
Published
Seppala, E.H., Reuser, A.J., Lohi, H. : A nonsense mutation in the acid ?-glucosidase gene causes Pompe disease in Finnish and Swedish Lapphunds. PLoS One 8:e56825, 2013. Pubmed reference: 23457621. DOI: 10.1371/journal.pone.0056825.
Breed Specific Info
Researched Breeds
Finnish Lapphund, Swedish Lapphund
